Skip to main content
. Author manuscript; available in PMC: 2021 Feb 1.
Published in final edited form as: Breast Cancer Res Treat. 2019 Nov 19;179(3):585–604. doi: 10.1007/s10549-019-05485-5

Fig. 7. Semi-automated quantification of ERRβ IHC.

Fig. 7.

A. Total percent (%) of patients that are ERRβ positive, by IHC subtype, *p<0.01. b. Ratio of total ERRβ2:total ERRβsf determined for ER+, HER2+, and TNBC patients. c-e. ERRβ expression by race. Interactions between ERRβ2 receptor expression (c,d) and ERRβsf expression (e,f) and race. Two- way ANOVA, followed by DSCF pair-wise comparison *p < 0.05